Jeong Hwan Choi

Dr. Jeong Hwan Choi

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2019 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
DRDouglas Ruhl
Douglas Ruhl
TDTing-Ting Du
Ting-Ting Du
EWElizabeth L. Wagner
Elizabeth L. Wagner
JCJeong Hwan Choi
Jeong Hwan Choi
SLSihan Li
Sihan Li
JSJung-Bum Shin
Jung-Bum Shin
Ototoxic side effects of cisplatin and aminoglycosides have been extensively studied, but no therapy is available to date. Sensory hair cells, upon exposure to cisplatin or aminoglycosides, undergo apoptotic and necrotic cell death. Blocking these cell death pathways has therapeutic potential in theory, but incomplete protection and lack of therapeutic targets in the case of necrosis, has hampered the development of clinically applicable drugs. Over the past decade, a novel form of necrosis, termed necroptosis, was established as an alternative cell death pathway. Necroptosis is distinguished from passive necrotic cell death, in that it follows a cellular program, involving the receptor-interacting protein kinase (RIPK) 1 and RIPK3. In this study, we used pharmacological and genetic interventions in the mouse to test the relative contributions of necroptosis and caspase-8-mediated apoptosis toward cisplatin and aminoglycoside ototoxicity. We find thatex vivo, only apoptosis contributes to cisplatin and aminoglycoside ototoxicity, whilein vivo, necroptosis as well as apoptosis are involved in both sexes. Inhibition of necroptosis and apoptosis using pharmacological compounds is thus a viable strategy to ameliorate aminoglycoside and cisplatin ototoxicity.SIGNIFICANCE STATEMENTThe clinical application of cisplatin and aminoglycosides is limited due to ototoxic side effects. Here, using pharmaceutical and genetic intervention, we present evidence that two types of programmed cell death, apoptosis and necroptosis, contribute to aminoglycoside and cisplatin ototoxicity. Key molecular factors mediating necroptosis are well characterized and druggable, presenting new avenues for pharmaceutical intervention.

1 July 2013 in American Journal of Otolaryngology
Verified
Journal Article
Closed access
JCJeong Hwan Choi
Jeong Hwan Choi

1 May 2011 in American Journal of Otolaryngology
Verified
Journal Article
Closed access
JCJeong Hwan Choi
Jeong Hwan Choi
HWHoon Young Woo
Hoon Young Woo
YYYoung Sam Yoo
Young Sam Yoo
KCKyoung Rai Cho
Kyoung Rai Cho

1 June 2012 in Otology & Neurotology
Verified
Journal Article
Closed access
JCJeong Hwan Choi
Jeong Hwan Choi

1 May 2013 in American Journal of Otolaryngology
Verified
Journal Article
Closed access
JCJeong Hwan Choi
Jeong Hwan Choi
HWHoon Young Woo
Hoon Young Woo

1 January 2012 in Korean Journal of Audiology
Verified
Journal Article
Open access
PDF file
SKSang Woo Kim
Sang Woo Kim
JCJeong Hwan Choi
Jeong Hwan Choi
Cerebrospinal fluid (CSF) leakage otorrhea may be congenital or can be caused by trauma, surgery, cholesteatoma, and tumors. Spontaneous CSF leakage through the middle ear without a secondary cause is a relatively rare disease. The pathophysiology of CSF otorrhea has not been clear yet. However, there are two theories of the pathophysiology of spontaneous CSF otorrhea have been studied in the medical field: one based on the congenital defect; the other about the arachnoid granulation which causes bone erosion. Herein, we examine and report a case of CSF otorrhea caused by arachnoid granulation. Literatures pertaining to the disorder will be reviewed and characteristics of the disorder also will be discussed.